|
PT672041E
(pt)
*
|
1993-10-01 |
2002-04-29 |
Novartis Ag |
Derivados da piridina farmacologicamente activos e processos para a sua preparacao
|
|
WO1995015973A1
(en)
|
1993-12-06 |
1995-06-15 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
US5510332A
(en)
*
|
1994-07-07 |
1996-04-23 |
Texas Biotechnology Corporation |
Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor
|
|
AU2964295A
(en)
|
1994-07-11 |
1996-02-09 |
Athena Neurosciences, Inc. |
Inhibitors of leukocyte adhesion
|
|
US5811391A
(en)
|
1994-08-25 |
1998-09-22 |
Cytel Corporation |
Cyclic CS-1 peptidomimetics, compositions and methods of using same
|
|
GB9524630D0
(en)
|
1994-12-24 |
1996-01-31 |
Zeneca Ltd |
Chemical compounds
|
|
WO1996031206A2
(en)
|
1995-04-07 |
1996-10-10 |
Warner-Lambert Company |
Flavones and coumarins as agents for the treatment of atherosclerosis
|
|
NZ321575A
(en)
|
1995-10-30 |
1999-05-28 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives
|
|
GB9522372D0
(en)
|
1995-11-01 |
1996-01-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US5704960A
(en)
|
1995-12-20 |
1998-01-06 |
Corning, Inc. |
Method of forming an optical fiber for reduced polarization effects in amplifiers
|
|
GB9603741D0
(en)
|
1996-02-22 |
1996-04-24 |
Lin Mei |
Treatment of water by electrolysis
|
|
ATE224884T1
(de)
*
|
1996-07-01 |
2002-10-15 |
Schering Corp |
Muscarin-antagonisten
|
|
US5935958A
(en)
*
|
1996-07-01 |
1999-08-10 |
Schering Corporation |
Muscarinic antagonists
|
|
AU729415B2
(en)
|
1996-07-12 |
2001-02-01 |
Millennium Pharmaceuticals, Inc. |
Chemokine receptor antagonists and methods of use therefor
|
|
JP2001517245A
(ja)
|
1997-05-29 |
2001-10-02 |
メルク エンド カンパニー インコーポレーテッド |
細胞接着阻害薬としてのビアリールアルカン酸類
|
|
EP1001764A4
(en)
|
1997-05-29 |
2005-08-24 |
Merck & Co Inc |
HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
|
|
AU7667498A
(en)
|
1997-05-30 |
1998-12-30 |
Celltech Therapeutics Limited |
Anti-inflammatory tyrosine derivatives
|
|
AU8163398A
(en)
|
1997-06-23 |
1999-01-04 |
Pharmacia & Upjohn Company |
Inhibitors of alpha4beta1mediated cell adhesion
|
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
|
US6391865B1
(en)
*
|
1999-05-04 |
2002-05-21 |
Schering Corporation |
Piperazine derivatives useful as CCR5 antagonists
|
|
US7825121B2
(en)
|
1999-05-04 |
2010-11-02 |
Schering Corporation |
Piperazine derivatives useful as CCR5 antagonists
|
|
KR100439357B1
(ko)
|
1999-05-04 |
2004-07-07 |
쉐링 코포레이션 |
Ｃｃｒ５ 길항제로서 유용한 피페리딘 유도체
|
|
SK287418B6
(sk)
|
1999-05-04 |
2010-09-07 |
Schering Corporation |
Farmaceutický prípravok s obsahom CCR5 antagonistov a súprava s obsahom tohto prípravku
|
|
US6387930B1
(en)
*
|
1999-05-04 |
2002-05-14 |
Schering Corporation |
Piperidine derivatives useful as CCR5 antagonists
|
|
US6635646B1
(en)
*
|
1999-05-04 |
2003-10-21 |
Schering Corporation |
Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
|
|
ES2165274B1
(es)
*
|
1999-06-04 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
|
|
JP4303969B2
(ja)
|
2001-03-29 |
2009-07-29 |
シェーリング コーポレイション |
Ｃｃｒ５アンタゴニストとして有用なアリールオキシム−ピペラジン
|
|
AR033452A1
(es)
*
|
2001-03-29 |
2003-12-17 |
Schering Corp |
Antagonistas de ccr5 utiles para el tratamiento del sida
|
|
AR036366A1
(es)
|
2001-08-29 |
2004-09-01 |
Schering Corp |
Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
|
|
SE0103818D0
(sv)
*
|
2001-11-15 |
2001-11-15 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2467555A1
(en)
|
2001-11-29 |
2003-08-14 |
Schering Corporation |
Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
|
|
AU2003207646C1
(en)
|
2002-01-22 |
2008-09-18 |
Vanderbilt University |
Treating stress response with chemokine receptor CCR5 modulators
|
|
US6992189B2
(en)
*
|
2002-03-29 |
2006-01-31 |
Schering Corporation |
Synthesis of piperidine and piperazine compounds as CCR5 antagonists
|
|
BR0312204A
(pt)
|
2002-06-27 |
2005-04-26 |
Schering Ag |
Antagonista de receptor ccr5 de quinolina substituìda
|
|
GB0223223D0
(en)
|
2002-10-07 |
2002-11-13 |
Novartis Ag |
Organic compounds
|
|
MY141736A
(en)
|
2002-10-08 |
2010-06-15 |
Elanco Animal Health Ireland |
Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists
|
|
WO2004056772A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists
|
|
EP1565436B1
(en)
|
2002-11-27 |
2012-04-25 |
Incyte Corporation |
3-aminopyrrolidine derivatives as modulators of chemokine receptors
|
|
DE60323765D1
(de)
*
|
2002-12-17 |
2008-11-06 |
Schering Corp |
Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
|
|
PE20040769A1
(es)
|
2002-12-18 |
2004-11-06 |
Schering Corp |
Derivados de piperidina utiles como antagonisas ccr5
|
|
EP1578744B1
(en)
|
2002-12-23 |
2008-07-09 |
Janssen Pharmaceutica N.V. |
Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
|
|
JO2485B1
(en)
|
2002-12-23 |
2009-01-20 |
شركة جانسين فارماسوتيكا ان. في |
1-Piperidine-3-Yl-4-Piperidine-4-Yl-Piperazine derivatives substituted and used as quinine antagonists
|
|
JO2696B1
(en)
|
2002-12-23 |
2013-03-03 |
شركة جانسين فارماسوتيكا ان. في |
Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
|
|
JP4660199B2
(ja)
|
2002-12-23 |
2011-03-30 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
置換１−ピペリジン−４−イル−４−アゼチジン−３−イル−ピペラジン誘導体およびそれらのニューロキニン拮抗薬としての使用
|
|
US20040235855A1
(en)
*
|
2003-03-31 |
2004-11-25 |
Bharat Lagu |
Phospholipase C inhibitors for use in treating inflammatory disorders
|
|
US20080070924A1
(en)
|
2003-06-10 |
2008-03-20 |
Frans Eduard Janssens |
Novel Formulations For Opioid-Based Treatments Of Pain Comprising 1-(1,2-Disubstituted Piperidinyl)-4-Substituted Piperazine Derivatives
|
|
RU2006100190A
(ru)
|
2003-06-13 |
2006-08-10 |
Шеринг Акциенгезельшафт (De) |
Производные хинолиламида в качестве антагонистов ccr-5
|
|
US7345042B2
(en)
*
|
2003-06-30 |
2008-03-18 |
Schering Corporation |
MCH antagonists for the treatment of obesity
|
|
KR20060100409A
(ko)
|
2003-11-03 |
2006-09-20 |
쉐링 코포레이션 |
케모킨 수용체 억제제로서 유용한 비피페리디닐 유도체
|
|
KR20080052683A
(ko)
*
|
2003-12-18 |
2008-06-11 |
인사이트 코포레이션 |
케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체
|
|
EA015517B1
(ru)
*
|
2004-04-13 |
2011-08-30 |
Инсайт Корпорейшн |
Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора
|
|
BRPI0510665A
(pt)
*
|
2004-05-11 |
2007-12-04 |
Incyte Corp |
3-(4-heteroarilcicloexilamino) ciclopentano-carboxiamidas como moduladores de receptores de quimiocinas
|
|
MXPA06014672A
(es)
*
|
2004-06-28 |
2007-03-26 |
Incyte Corp |
3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas.
|
|
WO2006004741A2
(en)
*
|
2004-06-28 |
2006-01-12 |
Incyte Corporation |
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
WO2006071875A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
SG158861A1
(en)
|
2005-01-06 |
2010-02-26 |
Schering Corp |
Synthesis of ccr5 receptor antagonists
|
|
EP1853583B1
(en)
|
2005-02-16 |
2011-09-07 |
Schering Corporation |
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
|
|
JP4873352B2
(ja)
|
2005-02-16 |
2012-02-08 |
シェーリング コーポレイション |
Ｃｘｃｒ３アンタゴニスト活性を有する、複素環で置換されたピペラジン
|
|
MX2007010068A
(es)
|
2005-02-16 |
2007-10-10 |
Schering Corp |
Piperazino-piperidinas con actividad antagonista de cxcr3.
|
|
JP2008530218A
(ja)
|
2005-02-16 |
2008-08-07 |
シェーリング コーポレイション |
Ｃｘｃｒ３アンタゴニスト活性を有する、ピリジルおよびフェニルで置換されたピペラジン−ピペリジン
|
|
MX2007010067A
(es)
|
2005-02-16 |
2007-12-07 |
Schering Corp |
Compuestos heterociclicos novedosos sustituidos con piridina o fenilo con actividad antagonista de cxcr3.
|
|
PE20061164A1
(es)
|
2005-02-16 |
2006-10-27 |
Schering Corp |
Piperazin-piperidinas sustituidas con pirazinilo con actividad antagonista de cxcr3
|
|
MX2007009949A
(es)
|
2005-02-16 |
2007-09-26 |
Schering Corp |
Pirazinil-piperazin-piperidinas sustituidas con heteroarilo con actividad antagonista de cxcr3.
|
|
EP1858887A1
(en)
|
2005-02-23 |
2007-11-28 |
Schering Corporation |
Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
|
|
JP4822367B2
(ja)
|
2005-02-23 |
2011-11-24 |
シェーリング コーポレイション |
ケモカイン受容体のインヒビターとして有用なピペリジニルピペリジン誘導体
|
|
MEP1008A
(xx)
*
|
2005-12-21 |
2010-02-10 |
Incyte Corp |
3-aminociklopentankarboksamidi kao modulatori receptora hemokina
|
|
TW200745087A
(en)
|
2006-02-24 |
2007-12-16 |
Schering Corp |
CCR5 antagonists useful for treating HIV
|
|
WO2008030853A2
(en)
*
|
2006-09-06 |
2008-03-13 |
Incyte Corporation |
Combination therapy for human immunodeficiency virus infection
|